Guardant Health (GH) PT Raised to $52 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Tejas Savant raised the price target on Guardant Health (NASDAQ: GH) to $52.00 (from $42.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
